Skip to content
MARKETS / NASDAQ / CBUS
NASDAQ · AGRICULTURAL CHEMICALS · SMALL CAP

Cibus, Inc. CBUS

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.6M
▼ 14.6% YoY
$-127.1M
$-51.2M
In brief

What this company does

Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ (RTDS®). Cibus’ primary business is focused on the development of plant traits for some of the world’s major agricultural crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. In the near term, Cibus’ priority pipeline program centers on Rice herbicide tolerance (HT) traits. Alongside its Rice program, Cibus also continues to advance its sustainable ingredients program, including lauric oils and bio fragrance products, the development of which is currently partially partner-funded and/or supported by a consumer-packaged goods partner. On July 21, 2025, the Board of Directors of Cibus (Board) approved a reduction in workforce of approximately 34 full-time employees as a pivotal step in implementing the Company’s streamlined business focus.

Written from the business description in Cibus, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 17 March 2026. Every sentence was checked against that document before publication.

Growth
USD 3.6M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 3.6 · Net income -127.1
-100M-200M201520172019202120232025
Compound annual growth
+185.1%
−31.3%
+11.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −31.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−3633 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -2680.1% · Net -3632.9%
-5000%-10000%-15000%201520172019202120232025
ROE
FY2025 · ROE -223.0%
-100%-200%201520172019202120232025

Each USD of equity lost 223 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -51.2
-20M-40M201520172019202120232025
Net buybacks $M Dividends $M
FY2019 · Dividends — · Net buybacks 0.8
-20M-40M201520182019

Total assetsUSD 305.0M
EquityUSD 21.8M
CashUSD 9.9M
Gross debtUSD 528,000.00
Net debtUSD -9.4M
Current ratio0.72×

The company holds more cash than debt.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.00.00.00.00.00.00.00.00.0
Net income $B−0.1−0.3−0.3−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.1−0.1−0.1−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−2.78−10.83−25.95−18.36−0.78−1.32−1.21−0.91−1.12−0.62−0.88
Dividend / sh $···········
Payout %··········−2
ROE %−223.0−130.4−178.0−158.1−114.5−90.2−50.8−37.0−73.6−64.7−24.3
Shares out B·0.030.020.050.040.040.030.030.030.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 46 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 47 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityAgricultural Chemicals
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image